The estimated Net Worth of Clarus Gp L.P.Blackstone Cl... is at least $9.52 Thousand dollars as of 12 November 2019. Clarus Cl owns over 250,000 units of Galera Therapeutics Inc stock worth over $9,522 and over the last 5 years Clarus sold GRTX stock worth over $0.
Clarus has made over 1 trades of the Galera Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Clarus bought 250,000 units of GRTX stock worth $3,000,000 on 12 November 2019.
The largest trade Clarus's ever made was buying 250,000 units of Galera Therapeutics Inc stock on 12 November 2019 worth over $3,000,000. On average, Clarus trades about 250,000 units every 0 days since 2019. As of 12 November 2019 Clarus still owns at least 130,444 units of Galera Therapeutics Inc stock.
You can see the complete history of Clarus Cl stock trades at the bottom of the page.
Over the last 5 years, insiders at Galera Therapeutics Inc have traded over $19,201,067 worth of Galera Therapeutics Inc stock and bought 3,540,438 units worth $29,883,202 . The most active insiders traders include Holdings A/S Novo, Group Inc Blackstone Group ..., and Bioventures Ltd Novartis Ag.... On average, Galera Therapeutics Inc executives and independent directors trade stock every 47 days with the average trade being worth of $11,809. The most recent stock trade was executed by Mel Sorensen on 16 August 2024, trading 67,015 units of GRTX stock currently worth $4,691.
galera therapeutics, inc. is a pharmaceuticals company located in 101 lindenwood dr, malvern, pennsylvania, united states.
Galera Therapeutics Inc executives and other stock owners filed with the SEC include: